In a review of its a2 Milk Co's investment thesis, UBS anticipates strong infant formula sales growth across both English-label and China-label via market share gains, helped by the China border reopening.The analyst highlights increased prices for a2 Platinum have resulted in stronger English-label reseller margins, while indicators for corporate daigou sell-out remain strong. UBS data also point to growing online brand strength.The Buy rating and target price of NZ$9.45 are retained.
In a review of its a2 Milk Co's investment thesis, UBS...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.04 |
Change
0.005(0.06%) |
Mkt cap ! $5.813B | |||
| Open | High | Low | Value | Volume |
| $8.05 | $8.11 | $8.02 | $3.857M | 479.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9777 | $8.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.04 | 3770 | 11 |
View Market Depth
| Last trade - 13.18pm 31/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |